Rare diseases collectively affect millions globally yet present unique diagnostic challenges due to their low prevalence and clinical heterogeneity. Genomic technologies have revolutionised rare ...
PM ETSAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2026. "The Bionano business is healthy, ...
White blood cells called neutrophils act as factories for C4A, linking peripheral immunity to schizophrenia and synaptic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results